pharmacokinet low-molecular-weight heparin unfraction heparin elect aortobifemor bypass graft periop monitor administr heparin empir basi wide variat patient respons elimin rate problem intervent basi periop monitor form heparin differ pharmacokinet properti unfraction heparin low-molecular-weight heparin bioavail subcutan administr linear clearanc mechan prolong half-lif effect postop vein thrombosi characterist low-molecular-weight heparin predict level heparin activ studi pharmacokinet low-molecular-weight heparin unfraction heparin intraven inject patient undergo aortic graft surgeri heparin activ heparin administr minut administr anti-xa activ low-molecular-weight heparin group variat sustain unfraction heparin group fibrin degrad product anti-factor Xa level low-molecular-weight heparin group correl unfraction heparin group anti-factor Xa activ low-molecular-weight heparin contrast unfraction heparin revers protamin administr blood loss compar group contrast pharmacokinet profil low-molecular-weight heparin unfraction heparin similar intraven inject patient undergo aortobifemor bypass graft factor pharmacokinet behavior heparin 